Kyntra Bio, Inc. (LON:0IL8)
London · Delayed Price · Currency is GBP · Price in USD 7.45
-0.20 (-2.61%)
At close: Feb 12, 2026
Kyntra Bio Market Cap
Kyntra Bio has a market cap or net worth of 22.21 million as of February 12, 2026. Its market cap has decreased by -44.04% in one year.
Market Cap
22.21M
Enterprise Value
-24.76M
Revenue
6.17M
Ranking
n/a
PE Ratio
0.14
Stock Price
7.45
Market Cap Chart
Since November 14, 2014, Kyntra Bio's market cap has decreased from 1.25B to 22.21M, a decrease of -98.22%. That is a compound annual growth rate of -30.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 23.13M | -12.37% |
| Dec 31, 2025 | 26.39M | -38.08% |
| Dec 31, 2024 | 42.62M | -37.71% |
| Dec 29, 2023 | 68.43M | -94.52% |
| Dec 30, 2022 | 1.25B | 29.40% |
| Dec 31, 2021 | 965.40M | -60.95% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 229.82B |
| GSK plc | 86.28B |
| Haleon | 36.19B |
| Smith & Nephew | 10.90B |
| Arecor Therapeutics | 27.94M |
| Abingdon Health | 26.00M |
| Aptamer Group | 24.95M |
| Sareum Holdings | 24.16M |